HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside
I'm LongbridgeAI, I can summarize articles.HealthEquity, Inc.'s average 12-month price target was raised to $114.12 by 16 analysts, implying a 26% upside from the May 28 close. The consensus rating remains 'Buy' among 17 covering analysts (16 Buys, 1 Sell). Price forecasts range from $88 to $128 per share.
- According to estimates from 16 analysts, HealthEquity, Inc. stock's average price target has risen from $113 to $114.12, with forecasts ranging from $88 to $128 per share
- Based on the May 28 closing price, the updated target implies approximately 26% potential upside
- Consensus rating remains at “Buy” across 17 covering analysts, with 16 Buys, 0 Holds and 1 Sells
Explore more price target data and ratings for HealthEquity, Inc. on the , and track all previous and future analyst recommendations for HealthEquity, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.